I[NTRODUCTION]{.smallcaps} {#sec1-1}
==========================

In 1943, the open bilateral posterior lumbar interbody fusion procedure was proposed by Cloward.\[[@ref1]\] This technique not only enables nerve root decompression but also interbody fusion from a single posterior approach.\[[@ref2]\] The clinical outcomes were satisfying. However, to further reduce the risk of neurological complications, transforaminal lumbar interbody fusion (TLIF), which achieves an interbody fusion through a unilateral posterior process, has obtained popularity.\[[@ref3]\] Since the introduction of TLIF by Harms and Rolinger, it has been used for treating multifarious lumbar degenerative disease.\[[@ref4][@ref5][@ref6][@ref7]\] TLIF results in higher rates of fusion compared with other interbody fusion approaches.\[[@ref4]\] In 2003, Foley *et al*.\[[@ref8]\] demonstrated that minimally invasive TLIF (MIS-TLIF) results in fewer muscle and tissue lesions compared with traditional open-TLIF; thus, this approach has a better outcome, although there are disadvantages.\[[@ref4]\]

Meta-analyses that have compared open-TLIF and MIS-TLIF have indicated that MIS-TLIF is associated with better functional outcomes, less blood loss, and a shorter hospital stay compared with open-TLIF. However, both of these procedures had no significant effect on the fusion rate, operation time, complications, or reoperation rate. Moreover, there were several limitations such as a lower evidence level and a lack of important data in some studies.\[[@ref4][@ref5][@ref6]\] Thus, we aimed to determine whether MIS-TLIF and open-TLIF had a significant effect on the fusion and complication rate with the technical development of the minimally invasive approach and the inclusion of additional studies. The question arose as to whether an updated meta-analysis would provide additional information and a higher clinic reference value. Thus, we aimed to provide an updated review of the literature to compare these two methods.

M[ETHODS]{.smallcaps} {#sec1-2}
=====================

This study was conducted in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-analyses.\[[@ref9]\]

Literature search {#sec2-1}
-----------------

The literature searches comprised Medical Subject Heading (MeSH) terms and key words in Medline: the MeSH term was degenerative intervertebral disc degeneration and the subheadings were surgery or therapy (*n* = 1146); the keywords combined "transforaminal lumbar interbody fusion" or "TLIF" with "MIS", "minimally invasive", or "minimally invasive spine surgery (*n* = 246)". In Embase, the Emtree term included intervertebral disk degeneration and the subheadings were surgery or therapy (*n* = 929); the keywords combined "transforaminal lumbar interbody fusion" or "TLIF" with "MIS", "minimally invasive", or "minimally invasive spine surgery (*n* = 327)". A web of science search was conducted by combining the keywords "transforaminal lumbar interbody fusion" or "TLIF" with "MIS", "minimally invasive", or "minimally invasive spine surgery (*n* = 386)". In China National Knowledge Infrastructure (CNKI), Wanfang, and VIP database, the search was conducted using the keywords "minimally invasive, MIS" and "transforaminal lumbar interbody fusion (CNKI = 154, Wanfang = 168, and VIP = 59)". A linguistic restriction was imposed on the search as recommended by the Cochrane Back Review Group editorial board.\[[@ref10][@ref11]\] The retrieval time ranged from the date when the database was founded to January 2015. To identify other relevant articles, the reference lists of the identified studies and review articles were also reviewed. Two reviewers independently screened all articles via the titles, abstracts, or full texts to determine the study inclusion. The authors and journals were known to the two reviewers. When different viewpoints occurred regarding a single study, a discussion ensued until a consensus was reached.

Study eligibility criteria {#sec2-2}
--------------------------

The inclusion criteria were as follows: (1) English and Chinese literature; (2) the study design was a comparative article (MIS-TLIF versus open-TLIF); (3) the article reported at least one clinic outcome or perioperative data; (4) the patients suffered from degenerative disc diseases (disc herniation, canal stenosis, or spondylolisthesis); isthmic spondylolisthesis was also included; (5) the sample size comprised at least ten patients for both groups; and (6) the full text was available. Reduplicated studies, case reports, cadaveric or biomechanical studies, non-English/Chinese articles, and patients treated via MIS-TLIF or open-TLIF for other diseases were excluded.

Data extraction {#sec2-3}
---------------

We obtained data from the included studies in the following categories: (1) authors and year of publication; (2) study design; (3) class of evidence; (4) total number of enrolled patients and number per group (MIS-TLIF and open-TLIF); (5) mean follow-up time; (6) follow-up time and rate (%); (7) mean age; (8) percentage of male and female patients; (9) diagnosis (divided into three categories: degenerative disc disease, spondylolisthesis, and others); (10) inclusion/exclusion criteria; (11) clinical outcomes; (12) perioperative data; (13) fusion definition and evaluation measure; (14) number of lumbar segments treated; (15) level of fusion (divided into L4--L5, L5--S1, and others); (16) use of grafts and types; (17) use of cages and types; (18) use of screw fixation and means; and (19) number of complications. We did not define complications in advance. Rather, the overall complications were collected.

Study quality {#sec2-4}
-------------

The study evidence class was determined using the Oxford Centre for Evidence-based Medicine-Levels of Evidence (March 2009). Good quality randomized controlled trials (RCTs) were considered Class I evidence. Moderate or poor quality RCT and good quality cohort studies were considered Class II evidence. Moderate or poor quality cohort studies and case--control studies were considered Class III evidence. Case series studies were considered Class IV evidence.\[[@ref12]\] The articles were independently assessed by two reviewers, and discrepancies were resolved by discussion until a consensus was reached.

Statistical analysis {#sec2-5}
--------------------

Continuous variables (Oswestry Disabilities Index \[ODI\], visual analog score \[VAS\], mean blood loss, length of stay, and operation time) were analyzed using weighted mean differences (WMDs) with the 95% confidence interval (*CI*). Dichotomous data (fusion rate, overall complication rate, and reoperation rate) were analyzed using the relative risk (*RR*) measure and 95% *CI*. The included studies were different in several variables such as the fusion definition, estimation of blood loss, VAS or ODI scale, surgical techniques, and patient conditions; thus, these variables were not the same for the overall studies within each group. Therefore, a random-effects model was more suited for this study because it enables a distribution in contrast to a fixed-effects model. All tests defined *P* \< 0.05 as significant. Funnel plots were used to assess the publication bias. A symmetrical plot indicates no bias, whereas an asymmetric plot indicates publication bias \[Supplementary Figure 1\]. Further analysis of the database was conducted using Review Manager 5.3 (Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2014).

###### 

Funnel plots: Complication rate. SE: Standard error; *RR*: Relative risk.

###### 

Click here for additional data file.

R[ESULTS]{.smallcaps} {#sec1-3}
=====================

Selected studies and characteristics {#sec2-6}
------------------------------------

The details of the search strategy and selection are shown in [Figure 1](#F1){ref-type="fig"}. We identified 24 eligible, comparative cohort studies from 780 potential studies in the initial literature search by independently judging the titles, abstracts, and full texts of all potential studies. The eligible studies included one RCT, eight prospective, and 15 retrospective cohort studies.\[[@ref13][@ref14][@ref15][@ref16][@ref17][@ref18][@ref19][@ref20][@ref21][@ref22][@ref23][@ref24][@ref25][@ref26][@ref27][@ref28][@ref29][@ref30][@ref31][@ref32][@ref33][@ref34][@ref35][@ref36]\] All included studies were written in English or Chinese, and the full text was available. Ten studies were excluded because they included data from patients in previously published studies\[[@ref37][@ref38][@ref39][@ref40][@ref41][@ref42][@ref43][@ref44][@ref45][@ref46]\] and seven studies were removed because the included diseases did not fulfill the inclusion criteria.\[[@ref47][@ref48][@ref49][@ref50][@ref51][@ref52][@ref53]\] One study had three subgroups, which were grouped by the number of surgery segments. We included only the one segment group because the number of patients in the other groups did not meet the inclusion criteria.\[[@ref20]\] There were 1967 patients in this study. There were 19 studies in which the diagnoses included degenerative disc disease; however, the diagnostic information was not clearly classified in two studies. Eighteen papers reported patients with only one segment surgery and one paper did not provide relevant information. The interbody device was used in all studies. All papers reported the use of bone graft information. Five of the included studies applied rhBMP-2.\[[@ref13][@ref14][@ref15][@ref23][@ref30]\] The detailed information regarding these studies is shown in [Table 1](#T1){ref-type="table"}.

![Flow diagram for the selection of studies.](CMJ-129-1969-g001){#F1}

###### 

Characteristics of the include trials

  ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Characteristics                          Wong *et al*.^\[[@ref25]\]^                                                                                                                                             Sulaiman and Singh^\[[@ref30]\]^                                                                                                                                                                          Tian *et al*.^\[[@ref31]\]^                                                                                                                                                                                                                                                                                Singh *et al*.^\[[@ref18]\]^                                                                                                                                                                                                                 Zheng *et al*.^\[[@ref32]\]^                                                                                                                                                                                          Chu *et al*.^\[[@ref36]\]^
  ---------------------------------------- ----------------------------------------------------------------------------------------------------------------------------------------------------------------------- --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- ------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Year of publication                      2014                                                                                                                                                                    2014                                                                                                                                                                                                      2014                                                                                                                                                                                                                                                                                                       2014                                                                                                                                                                                                                                         2014                                                                                                                                                                                                                  2014

  Study design                             Prospective cohort                                                                                                                                                      Retrospective cohort                                                                                                                                                                                      Retrospective cohort                                                                                                                                                                                                                                                                                       Retrospective cohort                                                                                                                                                                                                                         Retrospective cohort                                                                                                                                                                                                  Retrospective cohort

  Class of evidence\*                      III                                                                                                                                                                     III                                                                                                                                                                                                       III                                                                                                                                                                                                                                                                                                        III                                                                                                                                                                                                                                          III                                                                                                                                                                                                                   III

  Number of enrolled patient (MIS:open)    198 (144:54)                                                                                                                                                            68 (57:11)                                                                                                                                                                                                61 (30:31)                                                                                                                                                                                                                                                                                                 66 (33:33)                                                                                                                                                                                                                                   48 (22:26)                                                                                                                                                                                                            51 (15:36)

  Mean follow-up time (months; MIS:open)   45.0:46.0                                                                                                                                                               24:24                                                                                                                                                                                                     25.63:25.63                                                                                                                                                                                                                                                                                                6.0:6.0                                                                                                                                                                                                                                      12:12                                                                                                                                                                                                                 13.6:13.6

  Follow-up rate (%, months) (MIS:open)    100:100 (33) NR (\>33)                                                                                                                                                  100:100 (12) NR (\>12)                                                                                                                                                                                    100:100 (24) NR (\>24)                                                                                                                                                                                                                                                                                     100:100 (6)                                                                                                                                                                                                                                  100:100 (6) NR (\>6)                                                                                                                                                                                                  100:100 (6) NR (\>6)

  Mean age (years, MIS:open)               61.0:58.0                                                                                                                                                               61.1:56.4                                                                                                                                                                                                 48.21:48.90                                                                                                                                                                                                                                                                                                51.7:49.9                                                                                                                                                                                                                                    49.4:50.7                                                                                                                                                                                                             53:53

  Gender (% male; MIS:open)                42.4:46.3                                                                                                                                                               30:36                                                                                                                                                                                                     53:74                                                                                                                                                                                                                                                                                                      69.7:63.6                                                                                                                                                                                                                                    31.8:42.3                                                                                                                                                                                                             66.7:66.7

  Diagnosis (MIS:open)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     

   DDD                                     27:10                                                                                                                                                                                                                                                                                                                                                                             27:25                                                                                                                                                                                                                                                                                                      19:9                                                                                                                                                                                                                                         22:21                                                                                                                                                                                                                 15:36

   Spondylolisthesis                       66:25                                                                                                                                                                   57:11                                                                                                                                                                                                     3:6                                                                                                                                                                                                                                                                                                        6:9                                                                                                                                                                                                                                          0:5                                                                                                                                                                                                                   

   Others                                  51:24                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        8:5                                                                                                                                                                                                                                                                                                                                                                                                                                                                

  Inclusion/exclusion criteria             NR                                                                                                                                                                      Inclusion\                                                                                                                                                                                                 Inclusion\                                                                                                                                                                                                                                                                                                Inclusion\                                                                                                                                                                                                                                   Inclusion\                                                                                                                                                                                                            Inclusion\
                                                                                                                                                                                                                    Evidence on magnetic resonance imaging of Grades I or II degenerative lumbar spondylolisthesis; Mechanical low back pain and radicular leg symptoms\                                                      Symptomatic degenerative disease of the lumbosacral spine (L2 to S1)\                                                                                                                                                                                                                                      Diagnosis of either lumbar DDD, degenerative spondylolisthesis, or spinal stenosis; Patients had failed conservative management, including medications, a minimum of 6 weeks of physical therapy, and epidural injections when indicated\    Symptomatic and refractory to prior conservative treatment for low back pain with or without unilateral leg pain\                                                                                                     Patients need to have evidence on magnetic resonance imaging of lumbar DDD, degenerative\
                                                                                                                                                                                                                    Lack of response to at least 6 weeks of conservative therapy\                                                                                                                                             No response to nonoperative treatments for 6 months\                                                                                                                                                                                                                                                      Exclusion\                                                                                                                                                                                                                                    Single-level DDD or degenerative I grade spondylolisthesis; Lack of response to at least 12 weeks of conservative therapy\                                                                                            Have mechanical low back pain and radicular symptoms\
                                                                                                                                                                                                                    Age 18--80 years\                                                                                                                                                                                         Single-level involvement\                                                                                                                                                                                                                                                                                  Patients requiring 2 or more levels of fusion\                                                                                                                                                                                              Exclusion\                                                                                                                                                                                                             Unresponsive to at least 12 weeks of conservative therapy\
                                                                                                                                                                                                                   Exclusion\                                                                                                                                                                                                Exclusion\                                                                                                                                                                                                                                                                                                  Who were undergoing revision surgeries                                                                                                                                                                                                       Patients associated with previous spinal surgery, lumbar fracture, active infection, tumor, malformation\                                                                                                             At least 6 months of follow-up\
                                                                                                                                                                                                                    Patient had an active medical or worker's compensation lawsuit or any pre-existing spinal pathology                                                                                                       Age \<18 years or \>65 years\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           Patients who have severe adjacent segment degeneration                                                                                                                                                               Exclusion\
                                                                                                                                                                                                                                                                                                                                                                                                                             Previous lumbar surgery\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       NR
                                                                                                                                                                                                                                                                                                                                                                                                                             Osteoporosis spinal trauma or infections                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      

  Clinical outcome                         OPT, MBL, LOS, complications, VAS, ODI, fusion rate                                                                                                                     OPT, MBL, LOS, complications, VAS, ODI                                                                                                                                                                    OPT, MBL, LOS, complications, VAS, ODI, fusion rate, ambulation time                                                                                                                                                                                                                                       ORT, MBL, LOS, VAS                                                                                                                                                                                                                           OPT, MBL, complications, VAS, ODI, JOA, fusion rate                                                                                                                                                                   OPT, MBL, LOS, complications, VAS, ODI, fusion rate

  Definition fusion/evaluation measure     NR/dynamic flexion- extension lumbar radiographs in conjunction with a CT scan within the 16--24 months                                                                 NR                                                                                                                                                                                                        Grades I or II (Bridwell interbody fusion grading system)/radiographs (antero-posterior and lateral images) were employed to affirm the fusion rates and CT scans at 24 months                                                                                                                             NR                                                                                                                                                                                                                                           Trabecular bony bridges between contiguous vertebral bodies at the instrumented levels, and \<4° segmental movement/dynamic flexion-extension lumbar radiographs in conjunction with a CT scan within the 24 months   Trabecular bony bridges between contiguous vertebral bodies at the instrumented levels, and \<4° segmental movement/dynamic flexion-extension lumbar radiographs

  Surgical information                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     

   Number of segments treated              One (79:35) Two (55:21)                                                                                                                                                 One (45:2) Two (12:9)                                                                                                                                                                                     One (30:30)                                                                                                                                                                                                                                                                                                One (33:33)                                                                                                                                                                                                                                  One (22:26)                                                                                                                                                                                                           One (15:36)

   Level of fusion                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         

    L4--L5                                 62:14                                                                                                                                                                   37:8                                                                                                                                                                                                      14:17                                                                                                                                                                                                                                                                                                      NR                                                                                                                                                                                                                                           11:15                                                                                                                                                                                                                 NR

    L5 to S1                               65:21                                                                                                                                                                   12:9                                                                                                                                                                                                      14:13                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   11:10                                                                                                                                                                                                                 

    Others                                 17:9                                                                                                                                                                    2:4                                                                                                                                                                                                       2:1                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     0:1                                                                                                                                                                                                                   

   Interbody device                        PEEK cage                                                                                                                                                               PEEK cage                                                                                                                                                                                                 PEEK/titanium cage                                                                                                                                                                                                                                                                                         Cage                                                                                                                                                                                                                                         PEEK cage                                                                                                                                                                                                             Cage

   Graft use                               Autologous                                                                                                                                                              Autologous                                                                                                                                                                                                Autologous                                                                                                                                                                                                                                                                                                 Autologous                                                                                                                                                                                                                                   Autologous                                                                                                                                                                                                            Autologous

   Screw use                               Bilateral                                                                                                                                                               Bilateral                                                                                                                                                                                                 Bilateral                                                                                                                                                                                                                                                                                                  Bilateral (O)                                                                                                                                                                                                                                Bilateral                                                                                                                                                                                                             Bilateral

                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        Unilateral (MI)                                                                                                                                                                                                                                                                                                                                                                                                                                                    

                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           

  **Characteristics**                      **Parker *et al*.^\[[@ref17]\]^**                                                                                                                                       **Saetia *et al*.^\[[@ref29]\]^**                                                                                                                                                                         **Gu *et al*.^\[[@ref28]\]^**                                                                                                                                                                                                                                                                              **Brodano *et al*.^\[[@ref27]\]^**                                                                                                                                                                                                           **Zairi *et al*.^\[[@ref26]\]^**                                                                                                                                                                                      **Lau *et al*.^\[[@ref14]\]^**

                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           

  Year of publication                      2013                                                                                                                                                                    2013                                                                                                                                                                                                      2013                                                                                                                                                                                                                                                                                                       2013                                                                                                                                                                                                                                         2013                                                                                                                                                                                                                  2013

  Study design                             Prospective cohort                                                                                                                                                      Retrospective cohort                                                                                                                                                                                      Prospective cohort                                                                                                                                                                                                                                                                                         Retrospective cohort                                                                                                                                                                                                                         Retrospective cohort                                                                                                                                                                                                  Retrospective cohort

  Class of evidence\*                      II                                                                                                                                                                      III                                                                                                                                                                                                       III                                                                                                                                                                                                                                                                                                        III                                                                                                                                                                                                                                          III                                                                                                                                                                                                                   III

  Number of enrolled patient (MIS:open)    100 (50:50)                                                                                                                                                             24 (12:12)                                                                                                                                                                                                82 (44:38)                                                                                                                                                                                                                                                                                                 64 (30:34)                                                                                                                                                                                                                                   100 (40:60)                                                                                                                                                                                                           127 (78:49)

  Mean follow-up time (months; MIS:open)   24:24                                                                                                                                                                   28:28                                                                                                                                                                                                     20.6:20.0                                                                                                                                                                                                                                                                                                  23:25                                                                                                                                                                                                                                        27.0:30.0                                                                                                                                                                                                             NR

  Follow-up rate (%, months) (MIS:open)    100:100 (24)                                                                                                                                                            100:100 (24) NR (\>24)                                                                                                                                                                                    100:100 (16) NR (\>16)                                                                                                                                                                                                                                                                                     100:100 (12) NR (\>12)                                                                                                                                                                                                                       100:100 (24) NR (\>24)                                                                                                                                                                                                NR

  Mean age (years, MIS:open)               53.5:52.6                                                                                                                                                               63.10:67.40                                                                                                                                                                                               66.4:64.1                                                                                                                                                                                                                                                                                                  46:51                                                                                                                                                                                                                                        49:48                                                                                                                                                                                                                 54.1:52.5

  Gender (% male; MIS:open)                32.0:36.0                                                                                                                                                               10:50                                                                                                                                                                                                     43.1:39.5                                                                                                                                                                                                                                                                                                  60:58.8                                                                                                                                                                                                                                      50:47                                                                                                                                                                                                                 52.2:50.0

  Diagnosis (MIS:open)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     

   DDD                                                                                                                                                                                                                                                                                                                                                                                                                       15:11                                                                                                                                                                                                                                                                                                      30:34                                                                                                                                                                                                                                        18:25                                                                                                                                                                                                                 12:14

   Spondylolisthesis                       50:50                                                                                                                                                                   12:12                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             22:35                                                                                                                                                                                                                 11:24

   Others                                                                                                                                                                                                                                                                                                                                                                                                                    29:27                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         

  Inclusion/exclusion criteria             Inclusion\                                                                                                                                                              Inclusion\                                                                                                                                                                                                Inclusion:\                                                                                                                                                                                                                                                                                                Inclusion\                                                                                                                                                                                                                                   Inclusion\                                                                                                                                                                                                            Inclusion\
                                            Patients need to have evidence on magnetic resonance imaging of Grade I degenerative lumbar spondylolisthesis; Have mechanical low back pain and radicular symptoms\    Patients were Grades I or II spondylolisthesis presenting with mechanical low back pain, radiculopathy, and/or neurogenic claudication\                                                                   Two-level fusions were needed between L3 and S1\                                                                                                                                                                                                                                                           Symptomatic and refractory to prior conservative treatment low back pain with or without unilateral leg pain\                                                                                                                                Patients who underwent single-level TLIF for DDD or degenerative low-grade (1 or 2) spondylolisthesis\                                                                                                                NR\
                                            Unresponsive to at least 6 weeks of conservative therapy\                                                                                                               Preoperative evaluation with static (antero-posterior and lateral) and dynamic (flexion- extension) plain L-S spine radiography and MRI\                                                                  Persistent or recurrent low back pain or leg pain lasting at least 6 months and resulting in a significant reduction of quality of life, despite conservative therapy, including physical therapy and pain management\                                                                                     Single-level DDD or degenerative I grade spondylolisthesis documented with both X-Ray and MRI of the lumbar spine\                                                                                                                          Exclusion\                                                                                                                                                                                                            Exclusion\
                                            Age 18--70 years\                                                                                                                                                       Patients had failed conservative management (minimum 6 months) before surgery\                                                                                                                            Segmental instability was \>4 mm of translation or 10 of angular motion on preoperative flexion-extension radiographs\                                                                                                                                                                                     Minimum follow-up period after operation 6 months\                                                                                                                                                                                           Patients who underwent a multi-level TLIF and the patients with a history of lumbar arthrodesis                                                                                                                       Age \<18 years\
                                           Exclusion\                                                                                                                                                              Exclusion\                                                                                                                                                                                                Exclusion\                                                                                                                                                                                                                                                                                                 Exclusion:\                                                                                                                                                                                                                                                                                                                                                                                                                                                         BMI \<30.0 kg/m^2^\
                                            Undergone a previous back operation\                                                                                                                                     NR                                                                                                                                                                                                       Patients associated with previous spinal surgery, lumbar fracture, active infection, severe osteoporosis, and severe obesity\                                                                                                                                                                              Patients with DDD or degenerative spondylolisthesis at more than one level\                                                                                                                                                                                                                                                                                                                                                                                        TLIF of \>1 level\
                                            An extraspinal cause of back pain or sciatica\                                                                                                                                                                                                                                                                                                                                    Combination of coronal and/or sagittal deformities that needed a surgical correction\                                                                                                                                                                                                                      Patients with spinal stenosis with neurogenic claudication or bilateral leg pain\                                                                                                                                                                                                                                                                                                                                                                                  Patients who have undergone additional spinal instrumentation\
                                            An active medical or workman's compensation lawsuit\                                                                                                                                                                                                                                                                                                                              Degenerative spondylolisthesis with major instability or isthmic spondylolisthesis\                                                                                                                                                                                                                        Patients with isthmic spondylolisthesis\                                                                                                                                                                                                                                                                                                                                                                                                                           Patients who have undergone posterior fusion beyond 1 vertebra above and below the site of TLIF
                                            Any pre-existing spinal pathology\                                                                                                                                                                                                                                                                                                                                                Any major psychological problem                                                                                                                                                                                                                                                                            Patients with \<12 months follow-up\                                                                                                                                                                                                                                                                                                                                                                                                                              
                                            Unwilling or unable to participate with follow-up procedures                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 Patients who had previously undergone spinal surgery                                                                                                                                                                                                                                                                                                                                                                                                              

  Clinical outcome                         OPT, MBL, LOS, complications, VAS, ODI, SF-12, QALY, EQ-5D                                                                                                              OPT, MBL, LOS, complications, VAS, ODI, fusion rate                                                                                                                                                       OPT, MBL, LOS, complications, VAS, ODI, fusion rate                                                                                                                                                                                                                                                        OPT, MBL, LOS, complications, VAS, ODI, fusion rate                                                                                                                                                                                          OPT, MBL, LOS, complications, VAS, ODI, fusion rate                                                                                                                                                                   MBL, LOS, complications

  Definition fusion/evaluation measure     NR                                                                                                                                                                      Grades I or II (Bridwell interbody fusion grading System)/plain film and CT of the L-S spine at 24 months                                                                                                 Grades I or II (Bridwell interbody fusion grading system)/radiographs (AP and lateral images) at 12 months                                                                                                                                                                                                 NR/posterior-anterior and lateral view as well as dynamic X-rays of the lumbar spine (max flexion - max extension) at 12 months                                                                                                              Bony bridging anterior to the cage and bony continuity between the two endplates through the cage/CT scan at 12 months                                                                                                NR

  Surgical information                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     

   Number of segments treated              One (50:50)                                                                                                                                                             One (12:12)                                                                                                                                                                                               Two (44:38)                                                                                                                                                                                                                                                                                                One (30:34)                                                                                                                                                                                                                                  One (40:60)                                                                                                                                                                                                           One (23:38)

   Level of fusion                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         

    L4--L5                                 32:30                                                                                                                                                                   11:7                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 23:24 7:10                                                                                                                                                                                                                                   NR                                                                                                                                                                                                                    9:17 8:17 6:4

    L5 to S1                               14:17                                                                                                                                                                   1:3                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     

    Others                                 4:3                                                                                                                                                                     0:2                                                                                                                                                                                                       44:38                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         

    Interbody device                       Cage                                                                                                                                                                    Cage                                                                                                                                                                                                      PEEK cage                                                                                                                                                                                                                                                                                                  PEEK cage                                                                                                                                                                                                                                    PEEK cage                                                                                                                                                                                                             PEEK cage

    Graft use                              Autologous                                                                                                                                                              Autologous                                                                                                                                                                                                Autologous                                                                                                                                                                                                                                                                                                 Autologous                                                                                                                                                                                                                                   Autologous (30) BCP (30 + 40)                                                                                                                                                                                         Autologous

    Screw use                              Bilateral                                                                                                                                                               Bilateral                                                                                                                                                                                                 Bilateral                                                                                                                                                                                                                                                                                                  Unilateral                                                                                                                                                                                                                                   Bilateral                                                                                                                                                                                                             Bilateral

                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           

  **Characteristics**                      **Rodríguez-Vela *et al*.^\[[@ref19]\]^**                                                                                                                               **Yang *et al*.^\[[@ref33]\]^**                                                                                                                                                                           **Lee *et al*.^\[[@ref16]\]^**                                                                                                                                                                                                                                                                             **Lau *et al*.^\[[@ref15]\]^**                                                                                                                                                                                                               **Wang *et al*^\[[@ref34]\]^**                                                                                                                                                                                        **Liang *et al*.^\[[@ref35]\]^**

                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           

  Year of publication                      2013                                                                                                                                                                    2013                                                                                                                                                                                                      2012                                                                                                                                                                                                                                                                                                       2011                                                                                                                                                                                                                                         2011                                                                                                                                                                                                                  2011

  Study design                             Prospective cohort                                                                                                                                                      Retrospective cohort                                                                                                                                                                                      Prospective cohort                                                                                                                                                                                                                                                                                         Retrospective cohort                                                                                                                                                                                                                         Randomized controlled trial                                                                                                                                                                                           Retrospective cohort

  Class of evidence\*                      III                                                                                                                                                                     III                                                                                                                                                                                                       II                                                                                                                                                                                                                                                                                                         III                                                                                                                                                                                                                                          I                                                                                                                                                                                                                     III

  Number of enrolled patient (MIS:open)    41 (21:20)                                                                                                                                                              147 (43:104)                                                                                                                                                                                              144 (72:72)                                                                                                                                                                                                                                                                                                22 (10:12)                                                                                                                                                                                                                                   79 (41:38)                                                                                                                                                                                                            87 (42:45)

  Mean follow-up time (months; MIS:open)   45.0:45.0                                                                                                                                                               21:23                                                                                                                                                                                                     24.0:24.0                                                                                                                                                                                                                                                                                                  15.2:12.6                                                                                                                                                                                                                                    32.7:32.7                                                                                                                                                                                                             33.6:34.8

  Follow-up rate (%, months) (MIS:open)    100:100 (36) NR (\>36)                                                                                                                                                  100:100 (18) NR (\>18)                                                                                                                                                                                    95.8:100 (6) 95.8:91.7 (24)                                                                                                                                                                                                                                                                                100:100 (12) NR (\>12)                                                                                                                                                                                                                       100:100 (24) NR (\>24)                                                                                                                                                                                                100:100 (26) NR (\>26)

  Mean age (years, MIS:open)               41.81:43.15                                                                                                                                                             55:52                                                                                                                                                                                                     52.2:56.6                                                                                                                                                                                                                                                                                                  46.9:56.9                                                                                                                                                                                                                                    51.4:57.3                                                                                                                                                                                                             49.8:51.3

  Gender (% male; MIS:open)                66.7:65.0                                                                                                                                                               34.9:35.6                                                                                                                                                                                                 27.8:30.6                                                                                                                                                                                                                                                                                                  40.0:42.0                                                                                                                                                                                                                                    65.9:60.5                                                                                                                                                                                                             54.8:57.8

  Diagnosis (MIS:open)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     

   DDD                                     21:20                                                                                                                                                                   23:52                                                                                                                                                                                                     NR                                                                                                                                                                                                                                                                                                         5:6                                                                                                                                                                                                                                          30:24 11:14                                                                                                                                                                                                           42:45

   Spondylolisthesis                                                                                                                                                                                               20:52                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                4:6                                                                                                                                                                                                                                                                                                                                                                                                                                                                

   Others                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               1:0                                                                                                                                                                                                                                                                                                                                                                                                                                                                

  Inclusion/exclusion criteria             Inclusion\                                                                                                                                                              Inclusion\                                                                                                                                                                                                Inclusion\                                                                                                                                                                                                                                                                                                 NR                                                                                                                                                                                                                                           Inclusion\                                                                                                                                                                                                            Inclusion\
                                            Patients without previous medical conditions, who underwent a one-level TLIF\                                                                                           Diagnosis of either lumbar DDD, degenerative spondylolisthesis, or spinal stenosis\                                                                                                                       Single-level TLIF (open or MIS)\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        Unilateral or bilateral lower limb pain, numbness, or symptoms of intermittent claudication, with or without significant low back pain\                                                                               Diagnosis of either lumbar DDD, degenerative spondylolisthesis, or spinal stenosis\
                                            6 months of failed nonoperative treatment or neurologic deficit progression\                                                                                            No response to nonoperative treatments for 3 months\                                                                                                                                                      MIS cases utilizing sextant ITM\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        Imaging studies showing single-level lumbar disc herniation, spinal stenosis, or spondylolisthesis\                                                                                                                   Imaging studies showing single-level lumbar disc herniation, spinal stenosis or spondylolisthesis
                                            DDD\                                                                                                                                                                    Patients had clinic dates with at least 18 months of follow-up                                                                                                                                            (Medtronic, MN) pedicle screw-rod instrumentation and capstone (Medtronic MN) interbody cage\                                                                                                                                                                                                                                                                                                                                                                                                                                                           6 months of regular conservative treatment without relief of symptoms\                                                                                                                                               
                                           Exclusion:\                                                                                                                                                                                                                                                                                                                                                                       Exclusion\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               Informed consent                                                                                                                                                                                                     
                                            Patients with lumbar stenosis or isthmic spondylolisthesis                                                                                                                                                                                                                                                                                                                        Previous spinal instrumentation                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              

                                           Previous lumbar spine surgery (except single discectomy) Presence of MRI degenerative changes in other lumbar levels                                                    Exclusion\                                                                                                                                                                                                Tumor spinal pathologies Spinal infections Acute spinal trauma                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          Exclusion\                                                                                                                                                                                                            Exclusion\
                                                                                                                                                                                                                    Undergone a previous back operation\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              Multisegment lumbar disc herniation, spinal stenosis or, abnormal vertebral alignment\                                                                                                                                Undergone a previous back operation\
                                                                                                                                                                                                                    Any pre-existing spinal pathology\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                Severe osteoporosis or other metabolic bone disease\                                                                                                                                                                  Any pre-existing spinal pathology\
                                                                                                                                                                                                                    Any major psychological problem                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   Fractured vertebra, cracked pedicle, or a congenital, isthmic or other abnormal bone structure\                                                                                                                       Any major psychological problem
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      Infection in the intervertebral space or other areas\                                                                                                                                                                
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      Previous surgical treatment of segmental defects\                                                                                                                                                                    
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      Severe systemic disease which contraindicated surgery\                                                                                                                                                               
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      Consent not given                                                                                                                                                                                                    

  Clinical outcome                         Complications, VAS, ODI, SF-36, NASS                                                                                                                                    OPT, MBL, LOS, complications, VAS, ODI, fusion rate                                                                                                                                                       OPT, MBL, LOS, complications, VAS, ODI, fusion rate, SF-36, NASS, ambulation time                                                                                                                                                                                                                          ORT, MBL, complications, ambulation time, postoperative drainage, pain outcome scores                                                                                                                                                        OPT, MBL, LOS, complications, VAS, ODI                                                                                                                                                                                ORT, MBL, complications, VAS, ODI, fusion rate

  Definition fusion/evaluation measure     NR                                                                                                                                                                      Fusion was defined as Brantigan--Steffee classification D or E, translation movement \<2 mm and SA \<5°/dynamic flexion-extension lumbar radiographs in conjunction with a CT scan within the 12 months   The fusion was defined as Grades I or II. (Bridwell interbody fusion grading system)/static and dynamic plain at 6 months and 24 months                                                                                                                                                                    NR                                                                                                                                                                                                                                           NR                                                                                                                                                                                                                    NR

  Surgical information                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     

   Number of segments treated              One (21:20)                                                                                                                                                             One (43:104)                                                                                                                                                                                              One (72:72)                                                                                                                                                                                                                                                                                                One (9:7) Two (1:5)                                                                                                                                                                                                                          One (41:38)                                                                                                                                                                                                           One (42:45)

   Level of fusion                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         

    L4--L5                                 NR                                                                                                                                                                      24:63                                                                                                                                                                                                     54:49                                                                                                                                                                                                                                                                                                      5:6                                                                                                                                                                                                                                          11:15                                                                                                                                                                                                                 21:21

    L5 to S1                                                                                                                                                                                                       17:39                                                                                                                                                                                                     14:17                                                                                                                                                                                                                                                                                                      4:1                                                                                                                                                                                                                                          11:10                                                                                                                                                                                                                 16:11

    Others                                                                                                                                                                                                         2:2                                                                                                                                                                                                       4:6                                                                                                                                                                                                                                                                                                        1:5                                                                                                                                                                                                                                          0:1                                                                                                                                                                                                                   5:7

   Interbody device                        CIO®/CAPASTONE®                                                                                                                                                         Cage                                                                                                                                                                                                      PEEK/titanium cage                                                                                                                                                                                                                                                                                         Cage                                                                                                                                                                                                                                         PEEK cage                                                                                                                                                                                                             PEEK cage

   Graft use                               Autologous                                                                                                                                                              Autologous and DBM                                                                                                                                                                                        Autologous                                                                                                                                                                                                                                                                                                 Autologous                                                                                                                                                                                                                                   Autologous                                                                                                                                                                                                            PMMA

   Screw use                               Bilateral                                                                                                                                                               Bilateral                                                                                                                                                                                                 Bilateral                                                                                                                                                                                                                                                                                                  Bilateral                                                                                                                                                                                                                                    Bilateral                                                                                                                                                                                                             Bilateral

                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           

  **Characteristics**                      **Shunwu *et al*.^\[[@ref22]\]^**                                                                                                                                       **Wang *et al*.^\[[@ref24]\]^**                                                                                                                                                                           **Villavicencio *et al*.^\[[@ref23]\]^**                                                                                                                                                                                                                                                                   **Schizas *et al*.^\[[@ref21]\]^**                                                                                                                                                                                                           **Dhall *et al*.^\[[@ref13]\]^**                                                                                                                                                                                      **Scheufler *et al*.^\[[@ref20]\]^**

                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           

  Year of publication                      2010                                                                                                                                                                    2010                                                                                                                                                                                                      2010                                                                                                                                                                                                                                                                                                       2009                                                                                                                                                                                                                                         2008                                                                                                                                                                                                                  2007

  Study design                             Prospective cohort                                                                                                                                                      Prospective cohort                                                                                                                                                                                        Retrospective cohort                                                                                                                                                                                                                                                                                       Prospective cohort                                                                                                                                                                                                                           Retrospective cohort                                                                                                                                                                                                  Retrospective cohort

  Class of evidence\*                      II                                                                                                                                                                      III                                                                                                                                                                                                       III                                                                                                                                                                                                                                                                                                        III                                                                                                                                                                                                                                          III                                                                                                                                                                                                                   III

  Number of enrolled patient (MIS:open)    62 (32:30)                                                                                                                                                              85 (42:43)                                                                                                                                                                                                139 (76:63)                                                                                                                                                                                                                                                                                                36 (18:18)                                                                                                                                                                                                                                   42 (21:21)                                                                                                                                                                                                            94 (43:51)

  Mean follow-up time (months; MIS:open)   24.0:24.0                                                                                                                                                               26.3:26.3                                                                                                                                                                                                 37.5:37.5                                                                                                                                                                                                                                                                                                  22.0:24.0                                                                                                                                                                                                                                    24.0:34.0                                                                                                                                                                                                             16.0:16.0

  Follow-up rate (%, months) (MIS:open)    96:93 (24)\                                                                                                                                                             100:100 (13)\                                                                                                                                                                                             100:100 (24)\                                                                                                                                                                                                                                                                                              100:100 (12)\                                                                                                                                                                                                                                100:100 (\>12)\                                                                                                                                                                                                       100:100 (16)
                                           NR (\>24)                                                                                                                                                               NR (\>13)                                                                                                                                                                                                 NR (\>24)                                                                                                                                                                                                                                                                                                  NR (\>12)                                                                                                                                                                                                                                    38:62 (\>24)\                                                                                                                                                                                                         
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     19:38 (\>36)                                                                                                                                                                                                          

  Mean age (years, MIS:open)               51.4:52.0                                                                                                                                                               47.9:53.2                                                                                                                                                                                                 50.5:58.9                                                                                                                                                                                                                                                                                                  45.5:48.1                                                                                                                                                                                                                                    53.0:53.0                                                                                                                                                                                                             52.6:53.4

  Gender (% male; MIS:open)                56.3:46.7                                                                                                                                                               30.1:37.2                                                                                                                                                                                                 38.0:45.0                                                                                                                                                                                                                                                                                                  NR                                                                                                                                                                                                                                           NR                                                                                                                                                                                                                    45.2:47.8

  Diagnosis (MIS:open)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     

   DDD                                     14:8                                                                                                                                                                                                                                                                                                                                                                              NR                                                                                                                                                                                                                                                                                                         2:6                                                                                                                                                                                                                                          14:10                                                                                                                                                                                                                 18:25

   Spondylolisthesis                       5:8                                                                                                                                                                     24:22                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                15:12                                                                                                                                                                                                                                        7:11                                                                                                                                                                                                                  33:37

   Others                                  3:4                                                                                                                                                                     18:21                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                1:0                                                                                                                                                                                                                                                                                                                                                                                                                                                                

  Inclusion/exclusion criteria             Inclusion\                                                                                                                                                              Inclusion\                                                                                                                                                                                                Inclusion\                                                                                                                                                                                                                                                                                                 NR                                                                                                                                                                                                                                           Inclusion\                                                                                                                                                                                                            Inclusion\
                                            One-level pathological process\                                                                                                                                         Patients with degenerative or isthmic spondylolisthesis\                                                                                                                                                   At least 24 months of follow-up\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       Single-level DDD or degenerative Grade I spondylolisthesis\                                                                                                                                                           Patients presented with either axial back pain, neurogenic claudication, radiculopathy, pseudoradicular pain, or a combination of these\
                                            Patients were confirmed by antero-posterior and lateral plain radiographs, (CT) scans, and (MRI)\                                                                       Patients presented low back pain as their predominant complaint, with varying degrees of radiating pain, neurological complaints, or a combination of these\                                              Patients were confirmed by antero-posterior and lateral plain radiographs, (CT) scans, and (MRI)\                                                                                                                                                                                                                                                                                                                                                                                                                                                      Exclusion\                                                                                                                                                                                                             Unresponsive to at least 3 months of conservative therapy\
                                            Have low back pain, with varying degrees of radiating pain and neurologic symptoms\                                                                                     Unresponsive to at least 3 months of conservative therapy\                                                                                                                                                Unresponsive to at least 6 months of conservative therapy; unless their symptoms were progressive or existed in conjunction with major spinal instability confirmed in imaging studies\                                                                                                                                                                                                                                                                                                                                                                 NR Inclusion\                                                                                                                                                                                                        Exclusion\
                                            Unresponsive or inadequate to 6 months of conservative therapy\                                                                                                        Exclusion\                                                                                                                                                                                                Exclusion\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               Single-level DDD or degenerative Grade I spondylolisthesis\                                                                                                                                                           NR
                                           Exclusion\                                                                                                                                                               NR                                                                                                                                                                                                        NR                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     Exclusion\                                                                                                                                                                                                            
                                            Patients with previous spinal surgery                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     NR                                                                                                                                                                                                                   

  Clinical outcome                         OPT, MBL, LOS, complications, VAS, ODI, fusion rate, ambulation time, postoperative drainage                                                                            OPT, MBL, LOS, complications, VAS, ODI, fusion rate                                                                                                                                                       OPT, MBL, LOS, complications, VAS, fusion rate, MacNab's criteria                                                                                                                                                                                                                                          OPT, MBL, LOS, complications, VAS, ODI, fusion rate                                                                                                                                                                                          OPT, MBL, LOS, complications, fusion rate, mPS scores                                                                                                                                                                 OPT, MBL, VAS, fusion rate, Roland-Morris low back pain, AAOS-lumbar spine questionnaire

  Definition fusion/evaluation measure     Bony trabeculation crossed the cages or endplate interfaces/CT scans at 6 months                                                                                        Trabecular bony bridges between contiguous vertebral bodies at the instrumented levels, and \<4° segmental movement/static and dynamic plain X-rays at 6 months                                           Trabecular bone bridging on the CT scans and less than a 5° difference in angular motion between flexion and extension, and/or no radiolucency lines \>2 mm in thickness covering more than 50% of the superior or inferior surface of the grafts on the plain radiographs/CT scans or plain radiographs   NR/CT scans at 12 months                                                                                                                                                                                                                     NR/dynamic radiographs and with CT scans in questionable cases at 12 months                                                                                                                                           Formation of trabecular bony bridges between contiguous vertebral bodies at the instrumented levels/2-mm thin-slice CT scans at 16 months

  Surgical information                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     

   Number of segments treated              One (32:30)                                                                                                                                                             One (42:43)                                                                                                                                                                                               One (47:57) Two (16:19)                                                                                                                                                                                                                                                                                    NR                                                                                                                                                                                                                                           One (21:21)                                                                                                                                                                                                           One (43:51)

   Level of fusion                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         

    L4--L5                                 20 : 16                                                                                                                                                                 21 : 23                                                                                                                                                                                                   NR                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      NR                                                                                                                                                                                                                    NR

    L5 to S1                               11 : 12                                                                                                                                                                 18 : 17                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              12 : 11                                                                                                                                                                                                                                                                                                                                                                                                                                                            

   Others                                  1 : 2                                                                                                                                                                   3 : 3                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   

    Interbody device                       Titanium cage                                                                                                                                                           PEEK cage                                                                                                                                                                                                 Structural allograft                                                                                                                                                                                                                                                                                       PEEK cage                                                                                                                                                                                                                                    Cage                                                                                                                                                                                                                  PEEK cage

    Graft use                              Autologous                                                                                                                                                              Autologous                                                                                                                                                                                                Autologous                                                                                                                                                                                                                                                                                                 Autologous                                                                                                                                                                                                                                   Autologous                                                                                                                                                                                                            Autologous

    Screw use                              Bilateral                                                                                                                                                               Bilateral                                                                                                                                                                                                 Bilateral                                                                                                                                                                                                                                                                                                  Bilateral                                                                                                                                                                                                                                    Bilateral                                                                                                                                                                                                             Bilateral
  ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

\*Class of evidence was assessed by Oxford Centre for Evidence-based Medicine-Levels of Evidence (March 2009). MIS: Minimally invasive surgery; Open:open surgery; CT: Computed tomography; MRI: Magnetic resonance imaging; BCP: Biphasic calcium phosphate; PEEK: Polyether ether ketone; DBM: Demineralized bone matrix; PM: Polymethyl methacrylic; OPT: Operation time; MBL: Mean blood loss; LOS: Length of hospital stay; VAS: Visual analog score; ODI: Oswestry Disabilities Index; SF-36: Short Form 36 Health Survey; SF-12: Short Form 12 Health Survey; NASS: North American Spine Society; EQ-5D: EuroQol-5D; AAOS: American Academy of Orthopedic Surgeons; mPS: Modified Prolo Scale; NR: Not report; DDD: Degenerative disc disease; JOA: Japanese Orthopaedic Association Scores; L-S: Lumbo-sacral; TLIF: Transforaminal lumbar interbody fusion.

We also compared the baseline of the 24 included studies. One study considered nine aspects when comparing the two groups, five studies considered eight aspects, twelve studies considered seven aspects, three studies considered six aspects, two studies considered five aspects, and one study considered three aspects. However, there were different factors in the same number of aspects in the comparison of the MIS and open groups. There were significant differences between groups in several study variables, including the number of patients in both groups in eight studies, the mean age in one study and gender in one study. The other baseline characteristics were not significantly different between the two groups in the included studies \[[Table 2](#T2){ref-type="table"}\].

###### 

Comparison of baseline characteristics between the MIS group and open group

  Studies                                 Gender   Mean age   BMI   Number of enrolled patients   Level of surgery   Comorbidity   Preoperative diagnosis   Preoperative pain score   Preoperative function score
  --------------------------------------- -------- ---------- ----- ----------------------------- ------------------ ------------- ------------------------ ------------------------- -----------------------------
  Wong *et al*.^\[[@ref25]\]^             NS       NS         NR    S                             NS                 NR            NS                       NS                        NS
  Sulaiman and Singh^\[[@ref30]\]^        S        NS         NS    S                             S                  NR            NS                       NS                        NS
  Tian *et al*.^\[[@ref31]\]^             NS       NS         NS    NS                            NS                 NR            NS                       NS                        NS
  Singh *et al*.^\[[@ref18]\]^            NS       NS         NR    NS                            NS                 NR            NS                       NS                        NR
  Chu *et al*.^\[[@ref36]\]^              NS       NS         NR    S                             NS                 NR            NS                       NS                        NS
  Zheng *et al*.^\[[@ref32]\]^            NS       NS         NS    NS                            NS                 NS            NS                       NS                        NS
  Saetia *et al*.^\[[@ref29]\]^           S        NS         NS    NS                            NS                 NR            NS                       NS                        NS
  Gu *et al*.^\[[@ref28]\]^               NS       NS         NR    NS                            NS                 NR            NS                       NS                        NS
  Brodano *et al*.^\[[@ref27]\]^          NS       NS         NR    NS                            NS                 NR            NS                       NS                        NS
  Zairi *et al*.^\[[@ref26]\]^            NS       NS         NR    S                             NS                 NR            NS                       NS                        NS
  Lau *et al*.^\[[@ref14]\]^              NS       NS         NS    S                             NS                 NS            NS                       NR                        NR
  Rodríguez-Vela *et al*.^\[[@ref19]\]^   NS       NS         NR    NS                            NS                 NR            NR                       NS                        NS
  Parker *et al*.^\[[@ref17]\]^           NS       NS         NR    NS                            NS                 NR            NS                       NS                        NS
  Yang *et al*.^\[[@ref33]\]^             NS       NS         NR    S                             NS                 NR            NS                       NS                        NS
  Lee *et al*.^\[[@ref16]\]^              NS       NS         NS    NS                            NS                 NR            NS                       NS                        NS
  Lau *et al*.^\[[@ref15]\]^              NS       S          NR    NS                            NS                 NR            NS                       NR                        NS
  Wang *et al*.^\[[@ref34]\]^             NS       NS         NR    NS                            NS                 NR            NS                       NS                        NS
  Liang *et al*.^\[[@ref35]\]^            NS       NS         NR    NS                            NS                 NR            NS                       NS                        NS
  Shunwu *et al*.^\[[@ref22]\]^           NS       NS         NR    NS                            NS                 NR            NS                       NS                        NS
  Wang *et al*.^\[[@ref24]\]^             NS       NS         NR    NS                            NS                 NR            NS                       NS                        NS
  Villavicencio *et al*.^\[[@ref23]\]^    NS       NS         NR    S                             NS                 NR            NR                       NS                        NR
  Schizas *et al*.^\[[@ref21]\]^          NR       NR         NR    NS                            NR                 NR            NR                       NS                        NS
  Dhall *et al*.^\[[@ref13]\]^            NS       NS         NR    NS                            NR                 NR            NS                       NR                        NS
  Scheufler *et al*.^\[[@ref20]\]^        NS       NS         NR    S                             NS                 NS            NS                       NS                        NS

BMI: Body mass index; NS: No statistical significance (*P*\>0.05); S: Statistical significance (*P*\<0.05); NR: Not report; MIS: Minimally invasive surgery.

Methodological quality assessment {#sec2-7}
---------------------------------

There were one Level I evidence study, three Level II evidence studies, and twenty Level III evidence studies according to the previously described assessment criteria for class of evidence.

Meta-analysis results {#sec2-8}
---------------------

**Functional outcomes**

Multiple measurements were used to assess the patient functional outcome, such as lower back and/or leg pain VAS (VAS-BP/LP), ODI, EuroQol-5D, Japanese Orthopaedic Association Scores (JOA), Short Form 12 Health Survey or Short Form 36 Health Survey; however, the most reported measurements were the VAS-BP/LP and ODI. Thus, we selected these variables as the functional outcome standard. The mean preoperative VAS-LP was MIS: open = 7.0:6.9; the VAS-BP was MIS: open = 6.9:6.9; and the ODI was MIS: open = 49:50. The details are shown in [Table 3](#T3){ref-type="table"}, and there were no significant differences between the groups.

###### 

Preoperative VAS-BP/LP score and ODI of included studies (MIS: open), mean±SD

  Studies                                 VAS-BP                    VAS-LP                    ODI
  --------------------------------------- ------------------------- ------------------------- -----------------------------
  Wong *et al*.^\[[@ref25]\]^             6.37:6.72                 8.90:8.82                 52.8:51.2
  Sulaiman and Singh^\[[@ref30]\]^        7.3 ± 0.91:7.3 ± 1.41     NR                        53.7 ± 6.32:57.8 ± 9.41
  Tian *et al*.^\[[@ref31]\]^             4.86 ± 1.16:4.87 ± 1.29   6.35 ± 1.41:6.41 ± 1.32   43.56 ± 4.85:44.71 ± 5.42
  Singh *et al*.^\[[@ref18]\]^            6.94 ± 1.85:7.67 ± 1.29   NR                        NR
  Chu *et al*.^\[[@ref36]\]^              7.64 ± 0.78:7.64 ± 0.78   NR                        62.15 ± 4.51:59.17 ± 5.05
  Zheng *et al*.^\[[@ref32]\]^            4.9 ± 2.5:5.4 ± 2.2       6.6 ± 2.4:6.0 ± 2.8       23.3 ± 10.2:23.8 ± 9.0
  Saetia *et al*.^\[[@ref29]\]^           8.75 ± 1.60:7.92 ± 1.62   NR                        61.80 ± 12.89:58.33 ± 15.96
  Gu *et al*.^\[[@ref28]\]^               7.3 ± 1.2:7.4 ± 1.0       7.6 ± 0.9:7.7 ± 0.9       43.7 ± 4.3:44.3 ± 5.2
  Brodano *et al*.^\[[@ref27]\]^          7.8 ± 1.4:8.1 ± 1.5       NR                        42 ± 6.2:46 ± 7.1
  Zairi *et al*.^\[[@ref26]\]^            7.3:7.2                   7.1:6.8                   60:60
  Rodríguez-Vela *et al*.^\[[@ref19]\]^   7.04 ± 1.12:7.19 ± 2.21   7.31 ± 2.05:7.53 ± 1.23   28.85 ± 5.52:27.19 ± 8.19
  Parker *et al*.^\[[@ref17]\]^           8.1 ± 2.6:8.5 ± 2.2       6.5 ± 3.6:6.9 ± 3.3       32.3 ± 6.7:34.3 ± 7.9
  Yang *et al*.^\[[@ref33]\]^             7.79 ± 0.88:7.71 ± 0.86   NR                        57.95 ± 4.61:58.17 ± 5.05
  Lee *et al*.^\[[@ref16]\]^              6.3 ± 2.9:6.3 ± 2.9       5.8 ± 3.3:6.2 ± 3.1       48.1 ± 18.8:44.4 ± 18.0
  Wang *et al*.^\[[@ref34]\]^             4.9 ± 1.0:5.0 ± 1.0       NR                        58.8 ± 6.7:57.8 ± 6.7
  Liang *et al*.^\[[@ref35]\]^            5.7 ± 1.3:5.6 ± 1.4       7.1 ± 1.3:7.2 ± 1.3       80.9 ± 6.8:81.3 ± 7.5
  Shunwu *et al*.^\[[@ref22]\]^           6.8 ± 1.2:6.8 ± 1.4       NR                        49.7 ± 11.8:52 ± 12
  Wang *et al*.^\[[@ref24]\]^             7.2 ± 2.1:7.4 ± 1.6       NR                        41.2 ± 6.6:38.5 ± 7.4
  Villavicencio *et al*.^\[[@ref23]\]^    7.4:8.0                   NR                        NR
  Schizas *et al*.^\[[@ref21]\]^          7.7:5.0                   NR                        55:53

VAS-BP/LP: Visual analog score-back pain/leg pain; ODI: Oswestry Disabilities Index; SD: Standard deviation; NR: Not report; MIS: Minimally invasive surgery.

Twenty studies reported the VAS-BP; however, four studies only reported a mean VAS-BP score. Statistical analysis was feasible after standardization pooling to compare the functional outcome. The pooled postoperative analysis indicated that the MIS group had a significantly lower mean VAS-BP compared with the open group (WMD = −0.44; 95% *CI*: −0.71 to −0.18; *P* = 0.001; random-effects model) \[[Figure 2](#F2){ref-type="fig"}\]. In addition, nine studies reported the VAS-LP, including seven studies that reported the mean and standard deviation (SD) score. Statistical analysis was feasible after standardization pooling to compare the functional outcome. The pooled postoperative analysis indicated that the MIS group had a lower score; however, there was no significant difference between the groups (WMD = −0.10; 95% *CI*: −0.27 to 0.08; *P* = 0.26; random-effects model) \[[Figure 2](#F2){ref-type="fig"}\].

![Forest plot: postoperative VAS-BP/LP and ODI. MIS: Minimally invasive surgery; Open: Open surgery; VAS-BP/LP: Visual analog score-back pain/leg pain; ODI: Oswestry Disabilities Index; *CI*: Confidence interval; SD: Standard deviation.](CMJ-129-1969-g002){#F2}

Eighteen studies reported the ODI score; however, only 15 studies provided the mean and SD of the ODI. Statistical analysis was feasible after standardization pooling to compare the functional outcome. The pooled postoperative analysis indicated that the MIS group had a significantly lower ODI score compared with the open group (WMD = −1.57; 95% *CI*: −2.66 to −0.48; *P* = 0.005; random-effects model) \[[Figure 2](#F2){ref-type="fig"}\].

To more effectively compare both the procedures, we also pooled the mean VAS-LP, VAS-BP, and ODI improvement \[[Table 4](#T4){ref-type="table"}\]. The findings suggested that the MIS group exhibited a better outcome compared with the open procedure; the mean VAS-LP, VAS-BP, and ODI improvement were 0.2, 0.5, and 2.9, respectively.

###### 

Comparison between the MIS group and open group

  Mean             Fusion rate (%)   Complication rate (%)   Reoperation rate (%)   VAS-LP improvement   VAS-BP improvement   ODI improvement   MBL (ml)   OPT (min)   LOS (days)   Ambulation time (days)
  ---------------- ----------------- ----------------------- ---------------------- -------------------- -------------------- ----------------- ---------- ----------- ------------ ------------------------
  MIS (overall)    95.9              15.1                    0.4                    5.2                  4.7                  31.6              224.4      195         5.1          1.9
  Open (overall)   97.7              16.4                    0.5                    5.0                  4.2                  28.7              506.8      198         6.9          3.7

MIS: Minimally invasive surgery; Open: Open surgery; OPT: Operation time; MBL: Mean blood loss; LOS: Length of hospital stay; VAS-BP/LP: Visual analog score-back pain/leg pain; ODI: Oswestry Disabilities Index.

**Operation time**

Twenty-two studies reported the mean operation time; however, only 15 studies provided both the mean and SD of the operation time. Statistical analysis was feasible after standardization pooling to compare the functional outcome. The pooled postoperative analysis indicated that MIS had similar operation time to open group (WMD = −5.23; 95% *CI*: −50.55 to 40.09; *P* = 0.82; random-effects model) \[[Figure 3](#F3){ref-type="fig"}\].

![Forest plot: Operation time, mean blood loss, hosptial stay, and ambulation time. MIS: Minimally invasive surgery; Open: Open surgery; *CI*: Confidence interval; SD: Standard deviation.](CMJ-129-1969-g003){#F3}

We also compared the overall mean surgical operation time between the groups \[[Table 4](#T4){ref-type="table"}\]. The findings indicated that the operation time of the two groups was basically the same (MIS: open = 195:198).

**Mean blood loss**

Twenty-three studies reported the mean blood loss for both the MIS and open-TLIF procedures; however, seven studies did not provide the mean and SD of the mean blood loss. Statistical analysis was feasible after standardization pooling to compare the functional outcome. The findings indicated that there was less blood loss in the MIS group. The pooled analysis suggested that the MIS group had significantly less blood loss compared with the open group (WMD = −265.59; 95% *CI*: −351.31 to −179.86; *P* \< 0.00001; random-effects model) \[[Figure 3](#F3){ref-type="fig"}\].

We also compared the overall mean surgery estimation of blood loss between the groups \[[Table 4](#T4){ref-type="table"}\]. The findings indicated that MIS-TLIF was associated with less blood loss (224.4 ml) and reduced bleeding (506.8 ml).

**Length of hospital stay**

Twenty-one studies reported the mean length of stay; however, only 15 studies provided the mean and SD of the hospital stay. Statistical analysis was feasible after standardization pooling to compare the functional outcome. Nineteen studies indicated a shorter hospital stay in the MIS group. Our pooled analysis suggested that the MIS group had a significantly shorter length of stay compared with the open group (WMD = −1.89; 95% *CI*: −2.83 to −0.96; *P* \< 0.0001; random-effects model) \[[Figure 3](#F3){ref-type="fig"}\].

We also compared the overall mean length of stay between the groups \[[Table 3](#T3){ref-type="table"}\]. The findings suggested that MIS-TLIF decreased the hospital stay about 2 days compared with open-TLIF.

**Ambulation time**

Four studies reported the ambulation time; however, one study did not report the mean and SD. Statistical analysis was feasible after standardization pooling to compare the functional outcome. All studies indicated a shorter time to ambulate in the MIS group. The pooled analysis suggested that the MIS group had a significantly shorter ambulation time compared with the open group (WMD = −1.77; 95% *CI*: −2.68 to −0.86; *P* = 0.0001; random-effects model) \[[Figure 3](#F3){ref-type="fig"}\].

**Fusion rate**

Sixteen studies reported the fusion rate from a minimum of 6 months to a maximum of 24 months. Fusion was assessed with the use of dynamic flexion-extension radiographs and/or computed tomography scan. However, only 13 studies reported the fusion definition. The fusion rate was 95.9% (658/686) in the MIS-TLIF group and 97.7% (668/684) in the open-TLIF group. There was no significant difference in the fusion rate between the two groups (*RR* = 0.99; 95% *CI*: 0.97--1.01; *P* = 0.34; random-effects model) \[[Figure 4](#F4){ref-type="fig"}\].

![Forest plot: Fusion rate, complication rate, and reoperation rate. MIS: Minimally invasive surgery; Open: Open surgery; *CI*: Confidence interval.](CMJ-129-1969-g004){#F4}

**Complication rate**

Twenty-two studies reported the complication rate. The complication rate was 15.1% (142/940) in the MIS-TLIF group and 16.4% (142/867) in the open-TLIF group. The pooled analysis suggested that the MIS group had a lower complication rate; however, there was no significant difference between the two groups (*RR* = 0.84; 95% *CI*: 0.58--1.21; *P* = 0.35; random-effects model) \[[Figure 4](#F4){ref-type="fig"}\].

**Reoperation rate**

Thirteen studies reported the reoperation rate. The reoperation rate was 0.4% (34/788) in the MIS-TLIF group and 0.5% (37/767) in the open-TLIF group. The pooled analysis suggested that the MIS group had a lower reoperation rate; however, there was no significant difference between the two groups (*RR* = 0.73; 95% *CI*: 0.39--1.35; *P* = 0.32; random-effects model) \[[Figure 4](#F4){ref-type="fig"}\].

D[ISCUSSION]{.smallcaps} {#sec1-4}
========================

To determine the efficacy of both treatments, we analyzed the relative information as much detail as possible. Our findings indicated that MIS-TLIF had a better performance in all fields with the exception of the fusion rate \[[Table 4](#T4){ref-type="table"}\]. The meta-analysis suggested that MIS-TLIF attained a similar fusion rate, with a significantly shorter hospital stay and quicker ambulation, as well as less blood loss compared with open-TLIF. Patients suffered fewer lesions with less blood loss. MIS-TLIF resulted in quicker rehabilitation and less complications because patients exhibited earlier ambulation, as well as lower medical costs and a shorter hospital stay. For clinical functional outcomes, the preoperative baseline variables were similar between the groups, and the pooled analysis suggested that the MIS group exhibited significantly lower postoperative VAS and ODI scores compared with the open group. Thus, MIS-TLIF resulted in better outcomes and less trauma. These findings are consistent with the studies by Wu *et al*.\[[@ref4]\] and Tian *et al*.\[[@ref5]\]

Despite the many fusion technologies, TLIF has become a widely accepted and familiar surgical approach, which decreases the relative nervous complication rate.\[[@ref54][@ref55][@ref56]\] However, open-TLIF technology also requires splitting of the paraspinal muscle. Although it does not hurt, it breaks a major section of the posterior compartment, which may result in relevant muscle complications and low back pain.\[[@ref57]\] Therefore, minimally invasive TLIF was introduced by Foley and Lefkowitz\[[@ref58]\] approximately 10 years ago. To date, it has become an increasingly accepted approach with advantages, compared with traditional open surgery, that are attributed to decreased damage to spinal soft tissues and paravertebral muscles.\[[@ref20][@ref56][@ref59]\]

The advantages associated with MIS-TLIF may be attributed to the less intraoperative dissection and retraction of paravertebral muscles.\[[@ref4][@ref5][@ref8][@ref60]\]

Our meta-analysis indicated that MIS-TLIF was associated with a shorter operation time and lower complication and reoperation rate; however, there was no significant difference between MIS and open-TLIF, which is consistent with the findings of Tian *et al*.\[[@ref5]\] Nevertheless, it is interesting that the compilation and reoperation rate were significantly decreased in the MIS group compared with the open-TLIF group. As shown in [Figure 5](#F5){ref-type="fig"}, there are several potential reasons for this phenomenon; one major reason may be that the learning curve is very steep and it requires more years and experience to absorb and master minimally invasive surgery skills.\[[@ref5][@ref13][@ref15][@ref21]\] The other major one may be possible with surgical devices and the development of equipment.

![Forest plot: Complication rate and reoperation rate. MIS: Minimally invasive surgery; Open: Open surgery; *CI*: Confidence interval.](CMJ-129-1969-g005){#F5}

There are several potential weaknesses in our meta-analysis. First, we included only prospective and retrospective studies in this study; thus, methodological defects were inevitable in these studies and included incorrect blinding or nonblinding, data bias, insufficient baseline comparisons, and insufficient data collection. Second, there were fewer outcome measures in the current study; additional objective or subjective parameters should be used to estimate the clinical outcomes. Third, the fusion definition and judgment were different across the included studies. Moreover, many of the studies comprised short- or medium-term research. Additional, long-term, follow-up studies should be conducted to evaluate both the approaches. Finally, there was unavoidable bias when the data were pooled. Despite these limitations, this updated meta-analysis provides an important clinical reference for the field.

In conclusion, the current meta-analysis indicated that MIS-TLIF resulted in a similar fusion rate with better functional outcome, less blood loss, shorter ambulation, and hospital stay. Furthermore, MIS-TLIF was not associated with an increase in the complication or reoperation rate based on the existing evidence. Thus, we recommend minimally invasive surgery as the first option if the patient meets the indication because it results in fewer lesions, better outcome, and a similar fusion rate compared with the traditional open surgery. Interestingly, MIS-TLIF has been associated with significantly decreased complication and reoperation rate in the recent years. We suggest that this finding is a result of greater acceptance in using MIS-TLIF, familiarity with the procedure, the ability to grasp and master minimally invasive surgery skills, and the relevant development of surgical instructions and apparatuses. Additional, high-quality studies are needed to confirm these findings and further compare the two methods.

*Supplementary information is linked to the online version of the paper on the Chinese Medical Journal website*.
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